April 9, 2020

Coronavirus vaccine trial begins in September

Spread the love

Johnson and Johnson has announced that is has selected its lead candidate for a Covid-19 vaccine, after pre-clinical research. Johnson and Johnson and the US Biomedical Advanced Research and Development Authority have committed more than one billion US dollars towards the research and development of the coronavirus vaccine. Johnson and Johnson Global Head of Viral Vaccine Discovery and Translational Medicine, Hanneke Schuitemaker speaks.

Leave a Reply

%d bloggers like this:
%d bloggers like this: